Key facts
- AVADEL PHARMACEUTICALS PLC has 13 insiders with reported activity on this page.
- Net insider value flow over the last year: -$233,353,092.
- Recent transaction rows are available for direct filing-level review.
Insider Transactions Reported by 13 Insiders of AVADEL PHARMACEUTICALS PLC
- Location
- Dublin 2
Change
- Buy value: ; sell value: $233,353,092.
- Net share flow: -11,112,052.
Research use
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsNet insider flow leans to selling over the last 12 months. Net value: -$233,353,092.
Buys
$0
Shares: 0
Insiders: 0
Sells
$233,353,092
Shares: 11,112,052
Insiders: 1
Net
-$233,353,092
Shares: -11,112,052
Insiders: -1
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 11,112,052 | $0 | $233,353,092 | -$233,353,092 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
AVADEL PHARMACEUTICALS PLC executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Geoffrey Michael Glass | Director | $140,250 | Mixed | 12 Feb 2026 | ||
| Linda Palczuk | Director | $140,250 | Mixed | 12 Feb 2026 | ||
| Gregory J. Divis | Chief Executive Officer, Director | $0 | Mixed | 12 Feb 2026 | ||
| Naseem Amin | Director | $0 | Mixed | 12 Feb 2026 | ||
| Jerad G. Seurer | Gen. Counsel & Corp. Secretary | $0 | Mixed | 12 Feb 2026 | ||
| Thomas S. Mchugh | Chief Financial Officer | $0 | Mixed | 12 Feb 2026 | ||
| Mark Anthony McCamish | Director | $0 | Mixed | 12 Feb 2026 | ||
| Peter J. Thornton | Director | $0 | Mixed | 12 Feb 2026 | ||
| Weiss Asset Management LP | Former 10% Owner | $0 | -$233,353,092 | -100% | Mixed | 13 Feb 2026 |
| Eric J. Ende | Director | $0 | Mixed | 12 Feb 2026 | ||
| Susan Rodriguez | Chief Operating Officer | Mixed | 12 Feb 2026 | |||
| Douglas J. Williamson | Chief Medical Officer | Mixed | 14 Feb 2022 | |||
| Richard J. Kim | Chief Commercial Officer | Mixed | 20 Feb 2024 |
Top shareholders of AVADEL PHARMACEUTICALS PLC (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13D/G
|
— |
7%
|
6,742,480
|
$59,674,993 | $0 | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13D/G
|
The Vanguard Group |
5.7%
|
5,564,259
|
$49,243,692 | $0 | 30 Jun 2025 | |
| JANUS HENDERSON GROUP PLC |
13D/G
|
— |
1.9%
|
1,823,865
|
$39,176,620 | -$120,413,722 | 31 Dec 2025 | |
| BRANDES INVESTMENT PARTNERS, LP |
13D/G
|
— |
0.2%
|
218,835
|
$4,700,576 | -$117,105,674 | 31 Dec 2025 | |
| Geoffrey Michael Glass |
3/4/5
|
Director | — | — | $140,250 | — | 12 Feb 2026 | |
| Linda Palczuk |
3/4/5
|
Director | — | — | $140,250 | — | 12 Feb 2026 | |
| IFP Advisors, Inc |
13F
|
Company |
0%
|
20
|
$426 | — | 31 Mar 2026 | |
| HUNTINGTON NATIONAL BANK |
13F
|
Company |
0%
|
1
|
$16 | — | 31 Mar 2026 | |
| Jeffrey L. Gendell |
13D/G
|
— |
4.9%
|
4,839,357
|
— | $0 | 31 Dec 2025 | |
| Douglas J. Williamson |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
275,000
|
— | — | 14 Feb 2022 | |
| Richard J. Kim |
3/4/5
|
Chief Commercial Officer |
—
class O/S missing
|
147,000
|
— | — | 20 Feb 2024 |
Recent Insider Transactions by Companies or Individuals for AVADEL PHARMACEUTICALS PLC
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Weiss Asset Management LP | AVDL | Ordinary Shares | Sale | -100% | $233,353,092 | $21.00 | -11,112,052 | 0 | 13 Feb 2026 | See Footnote 2 |
| Susan Rodriguez | AVDL | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -300,000 | 0 | 12 Feb 2026 | Direct | ||
| Peter J. Thornton | AVDL | Ordinary Shares | Disposed to Issuer | -100% | -115,060 | 0 | 12 Feb 2026 | Direct | ||
| Peter J. Thornton | AVDL | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -241,000 | 0 | 12 Feb 2026 | Direct | ||
| Jerad G. Seurer | AVDL | Ordinary Shares | Disposed to Issuer | -100% | -23,496 | 0 | 12 Feb 2026 | Direct | ||
| Jerad G. Seurer | AVDL | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -491,500 | 0 | 12 Feb 2026 | Direct | ||
| Linda Palczuk | AVDL | Ordinary Shares | Disposed to Issuer | -100% | -78,905 | 0 | 12 Feb 2026 | Direct | ||
| Linda Palczuk | AVDL | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -266,000 | 0 | 12 Feb 2026 | By Trust | ||
| Thomas S. Mchugh | AVDL | Ordinary Shares | Disposed to Issuer | -100% | -100,400 | 0 | 12 Feb 2026 | Direct | ||
| Thomas S. Mchugh | AVDL | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -1,004,500 | 0 | 12 Feb 2026 | Direct | ||
| Mark Anthony McCamish | AVDL | Ordinary Shares | Disposed to Issuer | -100% | -67,025 | 0 | 12 Feb 2026 | By McCamish Charitable Remainder Trust | ||
| Mark Anthony McCamish | AVDL | Ordinary Shares | Disposed to Issuer | -100% | -22,000 | 0 | 12 Feb 2026 | Direct | ||
| Mark Anthony McCamish | AVDL | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -291,000 | 0 | 12 Feb 2026 | Direct | ||
| Geoffrey Michael Glass | AVDL | Ordinary Shares | Disposed to Issuer | -100% | -144,979 | 0 | 12 Feb 2026 | By Trust | ||
| Geoffrey Michael Glass | AVDL | Ordinary Shares | Disposed to Issuer | -100% | -22,005 | 0 | 12 Feb 2026 | Direct | ||
| Geoffrey Michael Glass | AVDL | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -241,000 | 0 | 12 Feb 2026 | By Trust | ||
| Eric J. Ende | AVDL | Ordinary Shares | Disposed to Issuer | -100% | -219,905 | 0 | 12 Feb 2026 | Direct | ||
| Eric J. Ende | AVDL | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -249,057 | 0 | 12 Feb 2026 | Direct | ||
| Gregory J. Divis | AVDL | Ordinary Shares | Disposed to Issuer | -100% | -10,000 | 0 | 12 Feb 2026 | By Trust | ||
| Gregory J. Divis | AVDL | Ordinary Shares | Disposed to Issuer | -100% | -211,105 | 0 | 12 Feb 2026 | Direct | ||
| Gregory J. Divis | AVDL | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -2,870,000 | 0 | 12 Feb 2026 | Direct | ||
| Naseem Amin | AVDL | Ordinary Shares | Disposed to Issuer | -100% | -22,000 | 0 | 12 Feb 2026 | Direct | ||
| Naseem Amin | AVDL | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -71,500 | 0 | 12 Feb 2026 | Direct | ||
| Mark Anthony McCamish | AVDL | Ordinary Shares | Gift | 67,025 | 67,025 | 04 Feb 2026 | By McCamish Charitable Remainder Trust | |||
| Mark Anthony McCamish | AVDL | Ordinary Shares | Gift | -100% | -67,025 | 0 | 04 Feb 2026 | By Matthew 5 LLC | ||
| Linda Palczuk | AVDL | Stock Option (Right to Buy) | Gift | -100% | -11,000 | 0 | 15 Sep 2025 | Direct | ||
| Geoffrey Michael Glass | AVDL | Stock Option (Right to Buy) | Gift | -100% | -11,000 | 0 | 15 Sep 2025 | Direct | ||
| Mark Anthony McCamish | AVDL | Ordinary Shares | Award | 100% | 11,000 | 22,000 | 29 Jul 2025 | Direct | ||
| Mark Anthony McCamish | AVDL | Stock Option (Right to Buy) | Award | 11,000 | 11,000 | 29 Jul 2025 | Direct | |||
| Linda Palczuk | AVDL | Ordinary Shares | Award | 16.2% | 11,000 | 78,900 | 29 Jul 2025 | Direct | ||
| Linda Palczuk | AVDL | Stock Option (Right to Buy) | Award | 11,000 | 11,000 | 29 Jul 2025 | Direct | |||
| Peter J. Thornton | AVDL | Ordinary Shares | Award | 10.6% | 11,000 | 115,055 | 29 Jul 2025 | Direct | ||
| Peter J. Thornton | AVDL | Stock Option (Right to Buy) | Award | 11,000 | 11,000 | 29 Jul 2025 | Direct | |||
| Geoffrey Michael Glass | AVDL | Ordinary Shares | Award | 100% | 11,000 | 22,000 | 29 Jul 2025 | Direct | ||
| Geoffrey Michael Glass | AVDL | Stock Option (Right to Buy) | Award | 11,000 | 11,000 | 29 Jul 2025 | Direct | |||
| Eric J. Ende | AVDL | Ordinary Shares | Award | 5.27% | 11,000 | 219,900 | 29 Jul 2025 | Direct | ||
| Eric J. Ende | AVDL | Stock Option (Right to Buy) | Award | 11,000 | 11,000 | 29 Jul 2025 | Direct | |||
| Naseem Amin | AVDL | Ordinary Shares | Award | 100% | 11,000 | 22,000 | 29 Jul 2025 | Direct | ||
| Naseem Amin | AVDL | Stock Option (Right to Buy) | Award | 11,000 | 11,000 | 29 Jul 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.